| 0 (0%) | 10-13 21:36 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1419.11 | 1-year : | 1657.53 |
| Resists | First : | 1215 | Second : | 1419.11 |
| Pivot price | 1168.19 |
|||
| Supports | First : | 1152.14 | Second : | 1113.29 |
| MAs | MA(5) : | 1177.34  |
MA(20) : | 1165.05 |
| MA(100) : | 1161.5 |
MA(250) : | 1053.29 |
|
| MACD | MACD : | 1.7 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 53.6 |
D(3) : | 55.1 |
| RSI | RSI(14): 49.9 |
|||
| 52-week | High : | 1292.65 | Low : | 778.93 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ LLY ] has closed above bottom band by 47.4%. Bollinger Bands are 49.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1194.7 - 1200.99 | 1200.99 - 1206.34 |
| Low: | 1143.57 - 1150.66 | 1150.66 - 1156.7 |
| Close: | 1154.88 - 1166.9 | 1166.9 - 1177.13 |
Tue, 13 Oct 2026
A Look at Eli Lilly and Co (LLY) After 1.4% Decline -- GF Value $1575.10 vs Price $1166.51 - GuruFocus
Tue, 13 Oct 2026
How Early Taltz and Zepbound Biomarker Synergies At Eli Lilly (LLY) Have Changed Its Investment Story - Yahoo Finance
Tue, 13 Oct 2026
Here's Why Eli Lilly (LLY) Fell More Than Broader Market - Yahoo Finance
Tue, 13 Oct 2026
What Is Eli Lilly Stock’s Biggest Opportunity? - Trefis
Tue, 13 Oct 2026
Prediction: Eli Lilly Could Have More Room to Grow Than Its Valuation Suggests - 24/7 Wall St.
Tue, 13 Oct 2026
BMO Capital Sticks to Its Buy Rating for Eli Lilly & Co (LLY) - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 892 (M) |
| Held by Insiders | 8.8892e+008 (%) |
| Held by Institutions | 0.1 (%) |
| Shares Short | 7,890 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 4.171e+010 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 26.2 |
| Profit Margin | 1.1 % |
| Operating Margin | 33.5 % |
| Return on Assets (ttm) | 54.2 % |
| Return on Equity (ttm) | 20.3 % |
| Qtrly Rev. Growth | 7.967e+010 % |
| Gross Profit (p.s.) | 106 |
| Sales Per Share | 227.31 |
| EBITDA (p.s.) | 1.47644e+011 |
| Qtrly Earnings Growth | 29.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 28,080 (M) |
| PE Ratio | 0 |
| PEG Ratio | 24.7 |
| Price to Book value | 44.52 |
| Price to Sales | 5.13 |
| Price to Cash Flow | 13.81 |
| Dividend | 0 |
| Forward Dividend | 7.04e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|